Diffuse scleroderma is a form of scleroderma that can cause the skin to tighten and thicken, and it can also affect organs such as the lungs, heart, kidneys, and digestive tract. Early symptoms of diffuse scleroderma often include swollen fingers, skin changes, heartburn, joint pain, and color changes in the hands in the cold. It most often begins in adults, and diffuse scleroderma usually lasts for years, although the course can vary from person to person. Not everyone will have the same experience. Treatment for diffuse scleroderma focuses on controlling inflammation, protecting affected organs, easing symptoms, and lowering the risk of serious complications, which can sometimes be life-threatening.
How many people live with Diffuse scleroderma?
Worldwide, pooled data suggest about 1.4 million people are living with the body-wide form of scleroderma, called systemic sclerosis (Bairkdar et al., 2021); because the diffuse type usually makes up about 30% to 40% of these cases, diffuse scleroderma is estimated at roughly 420,000 to 560,000 people worldwide, but that is an estimate rather than a direct count. In the United States, widely cited estimates suggest about 75,000 to 100,000 people live with systemic sclerosis (National Organization for Rare Disorders, 2024), so the diffuse type likely accounts for about 22,000 to 40,000 people, again as an estimate rather than a direct count.
Overview
Diffuse sclerodermaSymptoms
Diffuse scleroderma often causes skin thickening and tightening, especially on the hands, arms, face, and chest. Early symptoms of diffuse scleroderma can include puffy fingers, joint pain, heartburn, and fatigue. Some people also develop shortness of breath.
Outlook and prognosis
Diffuse scleroderma often changes most in the first few years, then may settle. Outlook depends mainly on lung, heart, and kidney involvement, so regular checks matter. Many people with diffuse scleroderma live longer with early treatment and close follow-up.
Causes and risk factors
Diffuse scleroderma likely results from immune system overactivity in people with a genetic tendency. Risk may be higher in women and with certain environmental exposures, such as silica dust or organic solvents.
Genetic influences
Genetics can raise the chance of diffuse scleroderma, but they are only part of the picture. Most people with diffuse scleroderma do not inherit it directly, and immune and environmental factors also seem to play important roles.
Diagnosis
Doctors diagnose diffuse scleroderma by combining your symptoms, a skin and physical exam, and blood tests for autoantibodies. They may also use lung, heart, or imaging tests to check internal organ involvement. Early diagnosis of diffuse scleroderma can guide treatment.
Treatment and drugs
Treatment for diffuse scleroderma focuses on protecting organs, easing symptoms, and slowing skin and lung changes. Many living with diffuse scleroderma take medicines for immune overactivity, blood pressure, reflux, pain, or circulation. Physical therapy and regular monitoring are also important.
Symptoms
Living with diffuse scleroderma can mean skin that feels tight and swollen, along with fatigue, joint stiffness, and circulation changes that make simple tasks harder. In diffuse scleroderma, symptoms may involve the skin, digestive tract, lungs, and other parts of the body, so the pattern is often broader than just skin changes. Symptoms vary from person to person and can change over time. Early symptoms of diffuse scleroderma can be easy to mistake for poor circulation, overuse, or heartburn.
Fingers or toes may turn white, blue, or purple in the cold or during stress, then throb, tingle, or hurt as blood flow returns. In diffuse scleroderma, this is often one of the first signs, and some people also develop numbness or painful sores at the fingertips.
Hands and fingers often become swollen and stiff, especially early on or in the morning. Rings may feel tight, and small tasks like buttoning clothes, typing, or opening jars can take more effort.
Skin can become tight, shiny, itchy, or uncomfortable across the hands, arms, face, chest, or abdomen. As it thickens, bending the fingers, reaching overhead, or opening the mouth wide may feel limited.
Aching joints and morning stiffness are common, and movement may feel sore or restricted. Many living with diffuse scleroderma also notice discomfort around tendons, especially in the hands, wrists, ankles, or knees.
How people usually first notice Diffuse scleroderma?
Diffuse scleroderma often first shows up in small, easy-to-miss ways: fingers that turn white, blue, or painful in the cold or during stress, puffy hands, and skin that starts to feel tight or swollen rather than soft and flexible. Many people living with diffuse scleroderma also notice new heartburn, trouble swallowing, aching joints, unusual fatigue, or that rings and shoes suddenly feel tighter because of swelling. These first signs of diffuse scleroderma can build over weeks to months, so what seems like dry skin or poor circulation at first is often the pattern that leads someone to seek medical care.
Types of Diffuse scleroderma
Diffuse scleroderma is itself a recognized form of systemic sclerosis, rather than a condition with clearly established subtypes of its own. In practice, doctors usually describe differences by how quickly symptoms appear, how much skin is involved, and whether internal organs are affected, not by separate named variants of diffuse scleroderma. Symptoms don’t always look the same for everyone, but no distinct types of diffuse scleroderma are widely recognized.
Can I slow down the onset of symptoms?
At this time, there is no proven way to meaningfully delay or prevent the start of diffuse scleroderma symptoms, and lifestyle changes have not been shown to stop the disease from beginning. Not smoking and taking good care of your overall health are still important because they may reduce stress on the blood vessels, lungs, and heart, but that is different from preventing diffuse scleroderma itself, and research on true prevention is still limited. There are no well-established screening tests or preventive medicines for people without symptoms, but getting checked quickly if early changes appear, such as fingers that react strongly to cold, swelling, or tightening skin, can help treatment start sooner and may improve day-to-day management.
What genetics can tell you about symptoms
Genetics can sometimes help explain why people with diffuse scleroderma have different symptom patterns, how quickly symptoms develop, and how serious skin or internal organ involvement may become, but genes are only part of the picture. Researchers have found that certain inherited genetic differences can raise the chance of developing this disease and may be linked to features such as earlier onset or a higher risk of lung problems, yet they do not predict a person’s exact symptoms with certainty. For many living with diffuse scleroderma, genetics offers clues about risk and patterns, while day-to-day symptoms are also shaped by the immune system, inflammation, and other factors doctors still do not fully understand.
Causes and risk factors
Diffuse scleroderma seems to start when the immune system becomes overactive and too much scar-like tissue builds up in the skin and sometimes inside the body. It’s rarely just one factor—it’s the mix that matters. Genes can raise susceptibility, and a family history of autoimmune illness may slightly increase the risk factors for diffuse scleroderma, but it usually is not passed down in a simple way. It is more common in women and often begins between ages 30 and 50, and some exposures such as silica dust or certain solvents may raise risk. Smoking does not clearly cause diffuse scleroderma, but it can worsen blood vessel problems and overall health.
What are the most common causes or risk factors?
The exact cause of diffuse scleroderma is not known, but it seems to develop when the immune system mistakenly attacks healthy tissue and the body makes too much scar-like tissue. It is more common in women, often begins between ages 30 and 50, and is more likely in people with a family history of the disease or certain inherited gene changes that affect the immune system, although it usually is not directly passed down from a parent. Long-term exposure to silica dust and some industrial solvents may also raise the risk in some people.
Environmental and biological risk factors
Diffuse scleroderma does not have one single known cause, and doctors think several body-based and environmental factors can raise risk. Being exposed to risks in your body or environment doesn't mean illness is inevitable. Understanding the main risk factors for diffuse scleroderma can help put those links in context.
Diffuse scleroderma is diagnosed more often in women than in men. Differences in immune activity and hormones may help explain part of this higher risk.
This condition most often begins in adulthood, especially from about ages 30 to 50. It can happen earlier or later, but risk is lower outside these years.
In the United States, diffuse scleroderma is seen more often in Black people and may begin at a younger age. This does not mean ethnicity causes the disease, but it is a recognized population-level risk pattern.
People whose immune system is more likely to misfire are at higher risk for autoimmune diseases, including diffuse scleroderma. This may be more noticeable in those who already have another autoimmune condition.
Genetic risk factors
Diffuse scleroderma can run in families, but most people who develop it do not inherit a single disease-causing gene. Instead, inherited changes in several immune-related genes can slightly raise the chance of diffuse scleroderma. It’s usually a combination of influences rather than one clear cause. These genetic risk factors for diffuse scleroderma help explain why the condition is more common in some families, but they do not mean someone will definitely become ill.
Family history: Having a close relative with scleroderma or another autoimmune disease can slightly raise the inherited risk of diffuse scleroderma. Even so, most people with diffuse scleroderma do not have a strong family history, and most relatives never develop it.
Polygenic risk: Diffuse scleroderma is usually linked to many small inherited gene variants working together rather than one single mutation. That is why it rarely follows a clear parent-to-child pattern.
HLA genes: Certain HLA genes are linked with a higher chance of diffuse scleroderma. These genes help the immune system recognize proteins, and inherited differences in them may make mistaken immune reactions more likely.
Immune genes: Changes in immune-control genes such as STAT4, IRF5, and PTPN22 have been associated with diffuse scleroderma. These variants can push the immune system toward inflammation, but they are not enough on their own to cause the disease.
Shared autoimmunity: Some of the same genes tied to diffuse scleroderma are also linked to other autoimmune conditions. This helps explain why different autoimmune diseases can appear in the same family.
Lifestyle risk factors
Daily habits do not fully explain why diffuse scleroderma develops, but they can meaningfully affect symptoms, complications, and quality of life. In practice, how lifestyle affects diffuse scleroderma is often most visible through circulation problems, reflux, lung health, joint stiffness, and fatigue. The most important modifiable factors are smoking, physical inactivity, eating patterns that worsen reflux, and habits that increase stress or poor sleep.
Smoking narrows blood vessels and can make Raynaud attacks, digital ulcers, and poor blood flow in the fingers worse. It may also add to lung and heart strain, which is especially important in diffuse scleroderma.
Too little movement can worsen stiffness, reduce flexibility, and contribute to loss of muscle strength and endurance. Regular, tailored exercise may help preserve joint function, mobility, and overall conditioning.
Large meals, late-night eating, and frequent intake of spicy, fatty, acidic, or highly processed foods can worsen acid reflux and swallowing discomfort. Poorly controlled reflux can further irritate the esophagus, which is a common problem in diffuse scleroderma.
Heavy alcohol use can aggravate reflux, disrupt sleep, and worsen fatigue. It may also interfere with coping, nutrition, and safe use of some medicines.
Risk prevention
There is no proven way to fully prevent diffuse scleroderma, because the exact cause is still not clear. Prevention is about lowering risk, not eliminating it completely. For many, the most practical steps are avoiding known harmful exposures, not smoking, and getting checked early if symptoms appear. Quick medical attention may not stop diffuse scleroderma from starting, but it can help reduce serious complications.
Smoking can injure blood vessels and may worsen the body changes linked to diffuse scleroderma. If you smoke, quitting is one of the most useful steps for overall vascular and lung health.
Long-term exposure to silica dust and some workplace solvents has been linked to a higher risk of scleroderma in some studies. Using proper protective equipment and following workplace safety rules may help lower avoidable risk.
Early symptoms of diffuse scleroderma can include puffy fingers, color changes in the hands with cold, heartburn, or tightening skin. Getting these checked promptly can lead to earlier treatment and closer monitoring.
Some may find it helpful to talk with a doctor about autoimmune symptoms, family history, and past job exposures. Knowing your risks can guide which preventive steps matter most.
Can you prevent Diffuse scleroderma?
No, there is no proven way to prevent diffuse scleroderma at this time, because doctors still do not fully know why it starts in some people. It is not caused by anything you did, and you cannot catch it from someone else. If you are living with it or may be at higher risk, not smoking and getting care early can help lower some problems, but they do not prevent the disease itself.
Transmission
Diffuse scleroderma is not contagious, so it cannot be caught from someone else through touch, kissing, coughing, sex, food, or shared spaces. It is an autoimmune condition, which means the immune system becomes overactive and starts affecting the body’s own tissues, rather than an infection that spreads from person to person.
When people ask about how diffuse scleroderma is inherited, the short answer is that it usually does not pass from parent to child in a simple, predictable way. Some families may share genes that slightly raise the risk, but most people with diffuse scleroderma do not have a close relative with the condition. For many, it seems to develop from a mix of genetic tendency and other triggers, not from direct transmission.
When to test your genes
For diffuse scleroderma, routine genetic testing is not recommended for early detection or to guide standard treatment. Care is usually tailored using symptoms, exam findings, autoantibody blood tests, and checks of the lungs, heart, kidneys, and digestive tract. Genetics may matter mainly in research or if your family history suggests a different inherited connective tissue disorder.
Diagnosis
Diffuse scleroderma is usually diagnosed by putting together your symptoms, a physical exam, and a few targeted tests rather than relying on one single result. Early on, people with diffuse scleroderma may notice tight or shiny skin, puffy fingers, heartburn, or shortness of breath, and these changes often lead to medical evaluation. Doctors usually begin by looking for patterns that fit the diagnosis of diffuse scleroderma and checking for signs that internal organs may also be affected.
Your doctor asks about skin tightening, color changes in the fingers with cold or stress, reflux, joint stiffness, and breathing symptoms. A detailed timeline helps show how quickly diffuse scleroderma has developed and which parts of the body may be involved.
The exam looks closely at skin thickening on the hands, arms, face, chest, or trunk, along with swollen fingers or small widened blood vessels on the skin. Your doctor also checks blood pressure, joints, heart, and lungs because diffuse scleroderma can affect more than the skin.
Blood tests look for antibodies linked with scleroderma and help rule out other autoimmune conditions. They may also check kidney function, inflammation, and muscle enzymes if weakness or pain is present.
Doctors may examine the tiny blood vessels at the base of the fingernails with a magnifier or microscope-like device. Changes in these vessels can support the diagnosis of diffuse scleroderma and show small-vessel damage.
How is Diffuse scleroderma diagnosed?
Diffuse scleroderma is usually diagnosed from a mix of your symptoms, a physical exam, and the pattern of skin thickening, along with blood tests that look for certain antibodies, which are proteins made by the immune system. Doctors also often check whether the lungs, heart, kidneys, or digestive system are affected by using breathing tests, heart tests, scans, and blood or urine tests, because this type can involve internal organs early on. There is no single test that proves it, so the diagnosis is made by putting all of these findings together and ruling out other causes of tight or hardened skin.
Stages of Diffuse scleroderma
Diffuse scleroderma can move through recognized stages, but the timing and severity can vary a lot from one person to another. In many living with diffuse scleroderma, skin changes spread more quickly in the first few years, while internal organ problems may appear early as well. Sometimes answers come quickly, while other times it takes longer, especially because the early symptoms of diffuse scleroderma can look different from person to person.
Swelling phase
The first stage often brings puffiness of the hands, fingers, feet, or face. Skin may feel tight, shiny, or unusually thick, and rings or shoes may stop fitting comfortably. Joint stiffness and Raynaud's symptoms, where fingers change color in the cold, are also common early on.
Hardening phase
Skin usually becomes firmer, thicker, and less flexible as the condition becomes more active. Many people notice trouble making a fist, reaching overhead, or opening their mouth fully. During this period, doctors also watch closely for lung, heart, kidney, and digestive involvement.
Thinning phase
Later, the skin may become less swollen and less hard, but it can also turn thinner and more fixed in place. Some areas may remain tight, with lasting limits in movement or hand function. Internal organ effects may stabilize in some people, while others still need ongoing monitoring and treatment.
Outlook and prognosis
The outlook for diffuse scleroderma varies widely, but it is generally more serious than limited forms because skin thickening appears earlier and internal organs are more often affected. Prognosis is driven mainly by the severity of lung disease, heart involvement, kidney complications, and gastrointestinal problems, with the highest risk often occurring in the first 3 to 5 years after symptoms begin. Survival has improved with earlier diagnosis and better treatment, and many people live for years or decades, especially when organ complications are recognized and managed promptly. However, diffuse cutaneous systemic sclerosis can still be life-threatening, particularly when it causes interstitial lung disease, pulmonary hypertension, scleroderma renal crisis, or significant cardiac disease. Mortality is higher than in the general population, with modern studies often reporting 5-year survival above 80% and 10-year survival around 60% to 80%, depending on the population and extent of organ involvement. Regular monitoring and treatment by specialists can meaningfully improve both quality of life and long-term outcomes.
Long-term effects
Diffuse scleroderma can affect daily life in lasting ways, from tight skin and stiff hands to breathlessness, reflux, and deep fatigue. The long-term picture is often shaped by which organs are involved and how active the disease is over time. Many living with diffuse scleroderma find that some changes stay fairly stable, while others need close follow-up because they can worsen slowly or lead to serious complications.
Skin may stay thick, tight, or less flexible for years, especially on the hands, face, and arms. For many, this can make dressing, writing, gripping objects, or fully opening the mouth harder.
Ongoing stiffness, pain, and reduced movement in the fingers, wrists, elbows, or shoulders can limit day-to-day tasks. Over time, some people with diffuse scleroderma develop contractures, meaning joints become harder to fully straighten or bend.
Scarring in the lungs can lead to a dry cough, shortness of breath, and lower exercise tolerance. One of the most important long-term effects is how diffuse scleroderma affects the lungs over time, because lung disease can become a major cause of illness.
Some people develop high blood pressure in the lung arteries, called pulmonary hypertension. This can cause breathlessness, chest pressure, dizziness, and strain on the heart.
How is it to live with Diffuse scleroderma?
Living with diffuse scleroderma can feel unpredictable because symptoms often reach beyond the skin, affecting energy, movement, digestion, breathing, and how comfortable everyday tasks feel. Many people with diffuse scleroderma find that pain, stiffness, fatigue, sensitivity to cold, and frequent medical visits can shape work, meals, sleep, and social plans, with some days feeling much harder than others. The condition can also affect loved ones, who may take on more practical help and emotional support, but with good medical care, pacing, and a strong support network, many people are able to adapt and protect their quality of life.
Treatment and drugs
Diffuse scleroderma is usually treated with a mix of medicines, careful monitoring, and day-to-day steps that aim to slow organ damage, ease symptoms, and help you stay as active and comfortable as possible. Because this condition can affect the skin, lungs, heart, kidneys, stomach, and joints, treatment is often tailored to the problems each person is having, such as drugs to calm an overactive immune system, medicines for acid reflux or high blood pressure in the lungs, and physical or occupational therapy to keep movement and hand function from becoming more limited. In daily life, that may mean one person needs help with painful, tight skin and finger ulcers, while another needs treatment for shortness of breath or trouble swallowing. Treatment often looks different for each person, and many living with diffuse scleroderma are cared for by a team that may include a rheumatologist plus lung, heart, kidney, skin, or digestive specialists. If you notice early symptoms of diffuse scleroderma getting worse, or new breathing trouble, chest pain, severe headache, or a sudden rise in blood pressure, prompt medical care is important because some complications need urgent treatment.
Can you cure Diffuse scleroderma?
No, there is currently no cure for diffuse scleroderma. Treatment focuses on helping manage symptoms, slowing down skin thickening and damage inside the body, and protecting organs such as the lungs, heart, kidneys, and stomach. Many people living with diffuse scleroderma do better with a mix of medicines, regular checkups, and supportive care like physical therapy and help with pain, reflux, or breathing problems.
Non-drug treatment
Living with diffuse scleroderma can affect everyday things like getting dressed, opening jars, eating comfortably, or walking without feeling tight and sore. Non-drug treatments often lay the foundation for staying mobile, protecting skin and joints, and managing problems such as reflux, breathlessness, and Raynaud attacks. Many people with diffuse scleroderma use a mix of rehabilitation, skin care, lifestyle changes, and practical supports tailored to which organs are affected. Not every approach works the same way, so care is usually adjusted over time.
Stretching and guided movement can help reduce stiffness and keep joints and muscles working as well as possible. For many, this can mean less trouble reaching overhead, standing up from a chair, or walking longer distances.
Occupational therapists can suggest hand exercises, splints, and easier ways to do daily tasks when fingers are tight or painful. They may also recommend tools such as jar openers, built-up handles, or button hooks to protect hand function.
Gentle aerobic activity and strengthening work can support stamina, mood, and joint mobility in diffuse scleroderma. Some strategies can slip naturally into your routine—like walking, cycling, or water exercise—without putting too much strain on sore joints.
Frequent moisturizing and careful protection of the hands can help with dry, tight, or cracked skin. If fingertip sores develop, prompt wound care and pressure relief can lower the risk of infection and help preserve hand use.
Your genes may have an impact on how drugs work for you
For people living with diffuse scleroderma, inherited differences in the body can sometimes change how medicines are broken down or how strongly they work, so one person may get good relief while another has less benefit or more side effects from treatments used for the immune system, blood pressure, pain, or reflux. In day-to-day life, this can look like one medicine easing skin tightness or lung inflammation for someone, while another person needs a different dose or a different treatment plan because of nausea, fatigue, or poor response. Genetic testing to guide treatment is not yet routine for diffuse scleroderma, but doctors may still adjust medicines carefully over time based on how each person responds.
Pharmacological treatments
Treatment for diffuse scleroderma usually targets the body systems most affected, such as the skin, lungs, blood vessels, stomach, and immune system. Commonly used medicines include mycophenolate mofetil, methotrexate, cyclophosphamide, rituximab, tocilizumab, and nintedanib, along with drugs for symptoms like reflux, Raynaud phenomenon, and high blood pressure in the lungs. Not everyone responds to the same medication in the same way. For many, this means treatment is adjusted over time as doctors watch symptoms, organ function, and side effects.
Mycophenolate mofetil is one of the most commonly used medicines for diffuse scleroderma, especially when skin thickening or lung scarring is present. It works by calming an overactive immune system and may help slow worsening of interstitial lung disease.
Methotrexate may be used when skin symptoms and joint inflammation are more prominent, particularly earlier in the disease course. It can help some people with skin tightness and stiffness, although it is usually not the main choice for serious lung disease.
Cyclophosphamide is a stronger immune-suppressing drug that may be used for significant lung involvement or rapidly worsening disease. Because side effects can be substantial, it is usually reserved for selected situations and monitored closely.
Rituximab is a targeted antibody treatment that may be used when diffuse scleroderma affects the skin or lungs and standard treatment is not enough. It is given by infusion and can be helpful for some people living with diffuse scleroderma, though follow-up is needed for infections and other risks.
Genetic influences
When skin tightening, Raynaud symptoms, and fatigue start interfering with daily life, many people wonder whether genes are part of the reason for diffuse scleroderma. Diffuse scleroderma does not usually come from one single inherited gene; instead, research suggests that several gene changes can slightly raise risk, especially in genes that help control the immune system. Family history is one of the strongest clues to a genetic influence, but most people with diffuse scleroderma do not have a close relative with the same illness.
For many living with diffuse scleroderma, this means genetics may set the stage, while other factors likely help trigger the disease. Having a genetic tendency is not the same as being destined to develop diffuse scleroderma, and relatives usually still have a low overall risk. At this point, routine genetic testing is not commonly used to predict diffuse scleroderma, but your doctor may still ask about family history to help put the bigger picture together.
Is Diffuse scleroderma genetic?
Genetics can raise the chance of diffuse scleroderma, but they are only part of the picture. Most people with diffuse scleroderma do not inherit it directly, and immune and environmental factors also seem to play important roles.
Having a genetic risk is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are widely present in the general population. Most do not have a direct effect on health and simply reflect natural differences among people. For many genes, having a variant associated with a condition suggests a possible link rather than a certain diagnosis, especially when more than one gene and environmental factors are involved. In some cases, though, a single well-characterized variant in a specific gene is enough to confirm the diagnosis.
Pharmacogenetics—how genetics influence drug effects
In diffuse scleroderma, treatment is often tailored because the disease can affect the skin, lungs, digestive tract, and blood vessels in different ways, and your genes may partly shape how you respond to some medicines. Variants in genes that affect how the liver handles drugs can change how quickly some people process pain medicines, antidepressants used for nerve pain, or acid reflux treatments, which can influence benefit or side effects. Genes involved in the immune system may also play a role in how well immune-calming drugs work for diffuse scleroderma, although this is still an active area of research rather than something doctors can predict reliably for everyone. Genetics is only one factor, and kidney or liver function, other medications, age, and which organs are involved often matter just as much when treatment is chosen. For many living with diffuse scleroderma, this means the best plan is still careful follow-up and dose adjustments over time, rather than a single genetic test that tells doctors exactly what to use. If you are wondering whether genetics could explain side effects or why treatment is not helping, that can be a reasonable question to raise, especially when early symptoms of diffuse scleroderma have led to several medication changes.
Interactions with other conditions
Diffuse scleroderma can affect more than the skin, so other health problems may become part of the picture over time. The biggest interactions are usually with the lungs, heart, kidneys, and digestive system: for example, some people develop scarring in the lungs or high blood pressure in the blood vessels of the lungs, while others may have acid reflux, trouble swallowing, or bowel problems that add to fatigue and weight loss. Having more than one diagnosis can make symptoms feel harder to untangle, especially when shortness of breath could come from lung involvement, heart strain, anemia, or another condition happening at the same time. Diffuse scleroderma also overlaps with other autoimmune diseases in some people, such as inflammatory muscle disease or thyroid disease, which can change symptoms and treatment needs. Infections can be more serious if the lungs are already affected or if treatment includes medicines that lower immune activity, so new fever, cough, or worsening breathlessness should be checked promptly. Because the early symptoms of diffuse scleroderma can blend with other illnesses, regular follow-up helps doctors spot these interactions early and adjust care before complications build up.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Diffuse scleroderma?
Other autoimmune illnesses, especially lupus, mixed connective tissue disease, and inflammatory muscle disease, can look similar because they may cause cold-sensitive color changes in the fingers, joint pain, fatigue, swelling, and skin changes. Localized scleroderma can also cause hard or tight skin, but it usually affects only certain areas and does not usually involve internal organs. Because these problems can overlap, doctors look at the full pattern of symptoms and test results, not just one sign.
History
Long before doctors could explain why it happens, people described an illness that slowly made the skin feel tight, stiff, and less able to stretch. Everyday tasks could become harder over time, like buttoning a shirt, opening a jar, or fully straightening the fingers in the morning. What we now call diffuse scleroderma was first recognized through these visible changes, often before its effects inside the body were understood.
First described in the medical literature as a disorder of hardening skin, scleroderma entered formal medicine in the 1700s, when European physicians began publishing detailed case reports. At first, these reports focused mostly on the skin. Over time, though, doctors noticed that some people had a more widespread form, with symptoms that moved beyond the hands or face and could affect larger areas of skin as well as organs such as the lungs, digestive tract, heart, or kidneys.
By the late 1800s and early 1900s, the picture became clearer. Diffuse scleroderma came to be recognized as part of a broader illness now known medically as systemic sclerosis, meaning the condition can involve the whole body rather than the skin alone. This was an important shift. It helped explain why someone with early symptoms of diffuse scleroderma might also have severe heartburn, shortness of breath, or circulation problems in the fingers, even if those issues seemed unrelated at first.
In the second half of the 20th century, doctors began sorting systemic sclerosis into patterns, including diffuse and limited forms. That mattered because these patterns can differ in how quickly skin changes appear and which internal organs may be at risk. Better blood testing, imaging, and closer long-term follow-up also helped doctors recognize complications earlier than in the past.
In recent decades, awareness has grown that diffuse scleroderma is not the same in every person. Many living with diffuse scleroderma have a different pace of illness, different symptom mix, and different response to treatment. Research has also shown that immune system changes, blood vessel injury, and scarring all play a role, and later studies identified a genetic contribution as part of the bigger picture. While there is still no cure, the history of diffuse scleroderma has moved steadily from simple skin descriptions to a much fuller understanding of a complex whole-body condition.